Eurofins CALIXAR’s approach allows to preserve the original structure and function of recombinant proteins (Kinases, Phosphatases, Ubiquitin, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors, Anchors and Viral Proteins) providing solutions for pharmaceutical industries, biotechnology companies and academic teams to develop conformational antibodies, formulate new vaccines, carry out Structure Based Drug Discovery and/or HTS assays.